Literature DB >> 10668113

Migraine and hypertension.

N T Mathew1.   

Abstract

Association between mild to moderate hypertension and headache is probably coincidental. Severe sustained hypertension, malignant hypertension and paroxysmal hypertension (sudden rise) are associated with severe headache. Transient hypertension can occur during an attack of migraine or cluster headache. Hypertension may increase the frequency and severity of migraine in migraineurs and may transform an episodic migraine into chronic daily headache. Concomitant treatment of hypertension is important in these patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10668113     DOI: 10.1177/0333102499019s2504

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  4 in total

Review 1.  Efficacy of frovatriptan and other triptans in the treatment of acute migraine of hypertensive and normotensive subjects: a review of randomized studies.

Authors:  V Tullo; G Bussone; S Omboni; P Barbanti; P Cortelli; M Curone; C Peccarisi; C Benedetto; D Pezzola; D Zava; G Allais
Journal:  Neurol Sci       Date:  2013-05       Impact factor: 3.307

2.  Lower Sodium Intake and Risk of Headaches: Results From the Trial of Nonpharmacologic Interventions in the Elderly.

Authors:  Liwei Chen; Zhenzhen Zhang; Wen Chen; Paul K Whelton; Lawrence J Appel
Journal:  Am J Public Health       Date:  2016-04-14       Impact factor: 9.308

3.  Efficacy and tolerability of intravenous methylergonovine in migraine female patients attending the emergency department: a pilot open-label study.

Authors:  Alfredo I Niño-Maldonado; Gary Caballero-García; Wilfrido Mercado-Bochero; Fernando Rico-Villademoros; Elena P Calandre
Journal:  Head Face Med       Date:  2009-11-08       Impact factor: 2.151

4.  Increased risk of hemorrhagic stroke in patients with migraine: a population-based cohort study.

Authors:  Cheng-Ya Kuo; Ming-Fang Yen; Li-Sheng Chen; Ching-Yuan Fann; Yueh-Hsia Chiu; Hsiu-Hsi Chen; Shin-Liang Pan
Journal:  PLoS One       Date:  2013-01-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.